Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862962
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2021-04-23
Brief Title:
Study to Evaluate the Safety of the Fixed-dose Combination RosuvastatinEzetimibe for Patients With Dyslipidaemia
Sponsor:
Laboratorios Silanes SA de CV
Organization:
Laboratorios Silanes SA de CV
Organization Data
Organization:
Laboratorios Silanes SA de CV
Class:
INDUSTRY
Study ID:
SIL-30231-IV-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Laboratorios Silanes SA de CV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None